Family Office Of America (FOFA) Total Current Liabilities (2021 - 2026)
Family Office Of America (FOFA) reported Total Current Liabilities of $787182.0 for Q1 2026, up 1485.33% on a YoY basis from $49654.0 in Q1 2025, and up 36.07% sequentially from $578533.0 in Q4 2025.
Family Office Of America (FOFA) Total Current Liabilities (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Total Current Liabilities data on file, last reported at $787182.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 1485.33% year-over-year to $787182.0; the trailing twelve-month figure through Mar 2026 stood at $787182.0 (up 1485.33% YoY), and the FY2025 full-year result was $578533.0, up 1214.22% from the prior year.
- Total Current Liabilities advanced to $787182.0 in Q1 2026, from $578533.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $787182.0 in Q1 2026 to a low of $20438.0 in Q2 2022.
- A 5-year average of $149406.2 and a median of $37049.5 in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities plunged 91.62% in 2024 and jumped 1485.33% in 2026, its largest moves.
- Tracing FOFA's Total Current Liabilities over 5 years: stood at $71507.0 in 2022, then jumped by 634.74% to $525387.0 in 2023, then sank by 91.62% to $44021.0 in 2024, then surged by 1214.22% to $578533.0 in 2025, then soared by 36.07% to $787182.0 in 2026.
- Business Quant data shows FOFA's Total Current Liabilities at $787182.0 in Q1 2026, $578533.0 in Q4 2025, and $25682.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 787,182.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 787,182.00 |
| Dec 31, 2025 | 578,533.00 |
| Sep 30, 2025 | 25,682.00 |
| Jun 30, 2025 | 34,375.00 |
| Mar 31, 2025 | 49,654.00 |
| Dec 31, 2024 | 44,021.00 |
| Sep 30, 2024 | 39,724.00 |
| Jun 30, 2024 | 33,800.00 |
| Mar 31, 2024 | 29,687.00 |
| Dec 31, 2023 | 525,387.00 |
| Sep 30, 2023 | 23,489.00 |
| Jun 30, 2023 | 22,489.00 |
| Mar 31, 2023 | 22,489.00 |
| Dec 31, 2022 | 71,507.00 |
| Sep 30, 2022 | 82,043.00 |
| Jun 30, 2022 | 20,438.00 |
| Dec 31, 2021 | 29,648.00 |